Search research articles
Contact Us
Filters
Showing results (281-290 of 314) with videos related to
Page
of 32
Sort By:
Journal of Racial and Ethnic Health Disparities
|
April 5, 2022
Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association's Get With The Guidelines Registry
Kevin S Shah, Adriana E Reyes-Miranda, Steven M Bradley, et al.
Scientific Reports
|
July 9, 2025
Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort
Ramya Madhavan, Divya Gupta, Jackwin Sam Paul, et al.
Gynecologic Oncology
|
June 11, 2022
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab
Melissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Journal of the American College of Cardiology
|
September 23, 2016
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure
G Michael Felker, Robert J Mentz, Robert T Cole, et al.
Frontiers in Molecular Biosciences
|
April 3, 2023
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters
Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, et al.
Journal of Cardiac Failure
|
February 27, 2018
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials
Michael S Kiernan, Susanna R Stevens, W H Wilson Tang, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India
|
May 10, 2024
Perioperative and functional outcomes following robot-assisted partial nephrectomy: Descriptive analysis of Indian study group on partial nephrectomy database
Sudhir Rawal, Arvind Ganpule, Gurpremjit Singh, et al.
JCO Precision Oncology
|
May 16, 2024
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial
Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, et al.
Cell
|
June 16, 2015
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Juan R Cubillos-Ruiz, Pedro C Silberman, Melanie R Rutkowski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 5, 2017
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation
Robert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 314) with videos related to
Sort By:
Page
of 32
Journal of Racial and Ethnic Health Disparities
|
April 5, 2022
Clinical Trial Participation and COVID-19: a Descriptive Analysis from the American Heart Association's Get With The Guidelines Registry
Kevin S Shah, Adriana E Reyes-Miranda, Steven M Bradley, et al.
Scientific Reports
|
July 9, 2025
Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort
Ramya Madhavan, Divya Gupta, Jackwin Sam Paul, et al.
Gynecologic Oncology
|
June 11, 2022
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab
Melissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Journal of the American College of Cardiology
|
September 23, 2016
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure
G Michael Felker, Robert J Mentz, Robert T Cole, et al.
Frontiers in Molecular Biosciences
|
April 3, 2023
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters
Shuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, et al.
Journal of Cardiac Failure
|
February 27, 2018
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials
Michael S Kiernan, Susanna R Stevens, W H Wilson Tang, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India
|
May 10, 2024
Perioperative and functional outcomes following robot-assisted partial nephrectomy: Descriptive analysis of Indian study group on partial nephrectomy database
Sudhir Rawal, Arvind Ganpule, Gurpremjit Singh, et al.
JCO Precision Oncology
|
May 16, 2024
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial
Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, et al.
Cell
|
June 16, 2015
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Juan R Cubillos-Ruiz, Pedro C Silberman, Melanie R Rutkowski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 5, 2017
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation
Robert Townsend Cole, Jonathan Gandhi, Robert A Bray, et al.
Page
of 32